BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato Gel .015%

  Picato Gel (ingenol mebutate) 0.015% is indicated for the topical treatment of actinic keratosis.

  October 25, 2017

   · 

  4 min read
• Business

  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results

  Neurocrine announced today that the Company will report third quarter 2017 results after the Nasdaq market close on November 1, 2017.

  October 25, 2017

   · 

  1 min read
• Business

  Jazz Pharma to Report 2017 Third Quarter Financial Results on November 7, 2017

  Jazz Pharma today announced that it will report its 2017 third quarter financial results on Tuesday, November 7, 2017, after the close of the financial markets.

  October 25, 2017

   · 

  1 min read
• Business

  Amgen Announces Appointment of Wanda M. Austin to Board of Directors

  Amgen today announced the appointment of Wanda M. Austin to its Board of Directors, effective upon the December Board and committee meetings.

  October 25, 2017

   · 

  2 min read
• Business

  Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017

  Vanda Pharma today announced it will release results for the third quarter of 2017 on Tuesday, November 7, 2017, after the market closes.

  October 25, 2017

   · 

  1 min read
• Business

  Alligator Bioscience Interim Report January-September 2017

  Three important collaborations in place. Results in November from ADC-1013 clinical phase I study.

  October 25, 2017

   · 

  4 min read
• The Scripps Research Institute New Study: ‘Double Decker’ Antibody Technology Fights Cancer

  Scientists from the Florida campus of The Scripps Research Institute have created a new class of ADCs, using a versatile “double decker""technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy.

  October 25, 2017

   · 

  3 min read
• Business

  United Therapeutics Corporation Reports Third Quarter 2017 Financial Results

  United Therapeutics today announced its financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  20 min read
• Business

  Cerapedics Announces Appointment of Doug Kohrs to Board of Directors and Names Antony Koblish Board Chair

  CeraPedics today announced the appointment of Doug Kohrs to the company’s board of directors and the appointment of Antony Koblish as board chair.

  October 25, 2017

   · 

  3 min read
• Business

  Baylis Medical’s Kris Shah appointed to AdvaMed Accel Board of Directors

  Baylis Medical Company has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors.

  October 25, 2017

   · 

  1 min read